biological product / Cancer treatment / iinnovative ti products / online docket / /
MedicalCondition
antithrombin deficiency / organ transplant Sickle cell disease Chronic / serious diseases / Preliminary disease area list Preliminary disease / Hereditary / arterial hypertension H / hemophilia A / sexual dysfunction Cancer / HIV / disease / angioedema Hereditary / risks Disease / von deficiency / Chronic / chronic inflammatory demyelinating polyneuropathy / young patients Cancer / VIII deficiency / sexual dysfunction / C deficiency / nominated disease / common variable immune deficiency / Pulmonary / Neurologic disorders / neuropathy Fibromyalgia Obesity Nocturia Chronic fatigue syndrome / Thrombotic disorders / disease Amyloidosis Aplastic anemia Melanoma Lung cancer Cancer / Nominated diseases / von Willebrand disease / pregnancy Cancer / Interstitial cystitis/painful bladder syndrome F / different disease / Depression / antitrypsin deficiency / disorders / Irritable bowel syndrome Inflammatory bowel disease Alopecia / /
MedicalTreatment
organ transplant / /
Organization
National Institute of Health / New Drugs Center for Drug Evaluation and Research / FDA Center for Drug Evaluation and Research / FDA / Rare Diseases Office / /
Person
Incorporating Patient Perspectives Anne Pariser / Theresa M. Mullin / /
Position
Director / Director for Planning / Major / Representative / /
Patient‐Focused Drug Development Public Meeting Public Meeting Theresa M. Mullin, Ph.D. Associate Director for Planning and Informatics FDA Center for Drug Evaluation and Research